Stay updated on NivoILP for In-Transit Metastases Clinical Trial
Sign up to get notified when there's something new on the NivoILP for In-Transit Metastases Clinical Trial page.

Latest updates to the NivoILP for In-Transit Metastases Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe NivoILP study record is displayed with its trial design, nivolumab and isolated limb perfusion treatment details, eligibility requirements, outcome measures, participating locations, and related publications.SummaryDifference56%

- Check19 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces NIH website updates and says that federal agencies are adopting “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error, with its footer revision updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating the requested study cannot be accessed, while the site's header and footer remain visible.SummaryDifference0.5%

Stay in the know with updates to NivoILP for In-Transit Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NivoILP for In-Transit Metastases Clinical Trial page.